 Chien Chen
Concepts (112)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Promoter Regions, Genetic | 3 | 2011 | 477 | 0.410 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 2 | 2001 | 21 | 0.390 |
Why?
| | Biopsy, Fine-Needle | 4 | 2015 | 103 | 0.250 |
Why?
| | DNA Methylation | 3 | 2011 | 548 | 0.250 |
Why?
| | Alleles | 2 | 2001 | 251 | 0.230 |
Why?
| | Dosage Compensation, Genetic | 1 | 2001 | 2 | 0.200 |
Why?
| | Nucleosomes | 1 | 2001 | 14 | 0.200 |
Why?
| | Gene Silencing | 1 | 2001 | 121 | 0.180 |
Why?
| | CpG Islands | 1 | 2001 | 107 | 0.180 |
Why?
| | Thyroid Neoplasms | 2 | 2012 | 109 | 0.170 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 253 | 0.170 |
Why?
| | Lung Neoplasms | 2 | 2015 | 605 | 0.170 |
Why?
| | Pulmonary Medicine | 1 | 2015 | 15 | 0.130 |
Why?
| | Cytodiagnosis | 1 | 2015 | 42 | 0.130 |
Why?
| | Genital Diseases, Male | 1 | 2015 | 17 | 0.130 |
Why?
| | Histiocytosis, Sinus | 1 | 2015 | 14 | 0.120 |
Why?
| | Scrotum | 1 | 2015 | 30 | 0.120 |
Why?
| | Endosonography | 1 | 2015 | 92 | 0.120 |
Why?
| | Lymph Nodes | 1 | 2015 | 264 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2012 | 11 | 0.110 |
Why?
| | Struma Ovarii | 1 | 2012 | 5 | 0.100 |
Why?
| | Thyroid Gland | 2 | 2012 | 73 | 0.100 |
Why?
| | Skin | 1 | 2015 | 407 | 0.100 |
Why?
| | Ovariectomy | 1 | 2012 | 119 | 0.100 |
Why?
| | Hybrid Cells | 2 | 2001 | 6 | 0.100 |
Why?
| | Carcinoma, Papillary | 1 | 2012 | 48 | 0.100 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2012 | 191 | 0.100 |
Why?
| | Cricetinae | 2 | 2001 | 192 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 86 | 0.090 |
Why?
| | Carcinoma, Medullary | 1 | 2010 | 12 | 0.090 |
Why?
| | Calcitonin | 1 | 2010 | 30 | 0.090 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 294 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2015 | 971 | 0.090 |
Why?
| | Base Sequence | 2 | 2001 | 650 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 797 | 0.090 |
Why?
| | Lipoproteins, LDL | 1 | 2011 | 170 | 0.090 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 319 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2011 | 269 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2011 | 214 | 0.080 |
Why?
| | Cell Line | 2 | 2001 | 1002 | 0.080 |
Why?
| | Thyroid Diseases | 1 | 2008 | 25 | 0.080 |
Why?
| | Blastomycosis | 1 | 2008 | 62 | 0.080 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 448 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2011 | 1007 | 0.070 |
Why?
| | Optic Nerve Neoplasms | 1 | 2005 | 8 | 0.070 |
Why?
| | Apoptosis | 1 | 2011 | 1100 | 0.070 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 54 | 0.060 |
Why?
| | Endoscopy | 1 | 2005 | 124 | 0.060 |
Why?
| | Hemangioma | 1 | 2005 | 83 | 0.060 |
Why?
| | DNA Footprinting | 1 | 2001 | 9 | 0.050 |
Why?
| | Humans | 10 | 2015 | 49827 | 0.050 |
Why?
| | Deoxyribonuclease I | 1 | 2001 | 34 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2001 | 135 | 0.050 |
Why?
| | X Chromosome | 1 | 2001 | 13 | 0.050 |
Why?
| | Azacitidine | 1 | 2001 | 34 | 0.050 |
Why?
| | Hydroxamic Acids | 1 | 2001 | 38 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2001 | 189 | 0.050 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2001 | 53 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2001 | 50 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2001 | 237 | 0.040 |
Why?
| | Animals | 3 | 2012 | 13150 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 595 | 0.040 |
Why?
| | Biopsy | 2 | 2015 | 582 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2001 | 1105 | 0.040 |
Why?
| | Male | 5 | 2015 | 25093 | 0.030 |
Why?
| | Female | 5 | 2015 | 26329 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 58 | 0.030 |
Why?
| | Middle Aged | 3 | 2015 | 11997 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 123 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 268 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 273 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 854 | 0.030 |
Why?
| | Organothiophosphorus Compounds | 1 | 2012 | 6 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2015 | 746 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2012 | 85 | 0.030 |
Why?
| | Hernia, Abdominal | 1 | 2012 | 5 | 0.030 |
Why?
| | Thyroglobulin | 1 | 2012 | 7 | 0.030 |
Why?
| | Activating Transcription Factor 1 | 1 | 2012 | 22 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2012 | 23 | 0.030 |
Why?
| | Rabbits | 1 | 2012 | 370 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2012 | 209 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 1422 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 64 | 0.020 |
Why?
| | Adolescent | 2 | 2015 | 6340 | 0.020 |
Why?
| | Chromogranin A | 1 | 2010 | 5 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2010 | 195 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 565 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 1952 | 0.020 |
Why?
| | Ultrasonography | 1 | 2012 | 436 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2015 | 2179 | 0.020 |
Why?
| | Aged | 2 | 2015 | 9272 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 231 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 2344 | 0.020 |
Why?
| | Scavenger Receptors, Class E | 1 | 2011 | 204 | 0.020 |
Why?
| | Phenotype | 1 | 2011 | 727 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 3125 | 0.020 |
Why?
| | Eye | 1 | 2008 | 31 | 0.020 |
Why?
| | Disease Progression | 1 | 2010 | 822 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2011 | 1571 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2012 | 1451 | 0.020 |
Why?
| | Infant | 1 | 2015 | 3551 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 979 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 829 | 0.020 |
Why?
| | Young Adult | 1 | 2015 | 3936 | 0.020 |
Why?
| | Blindness | 1 | 2005 | 31 | 0.020 |
Why?
| | Adult | 2 | 2015 | 13160 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2008 | 1036 | 0.010 |
Why?
| | Lung | 1 | 2008 | 480 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 6117 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 1159 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 1533 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2005 | 5138 | 0.010 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|